Aredia

Active Ingredient(s): Pamidronate
FDA Approved: * October 31, 1991
Pharm Company: * NOVARTIS
Category: Hypercalcaemia

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Aredia Overview

Pamidronic acid (INN) or pamidronate disodium (USAN), pamidronate disodium pentahydrate (marketed as Aredia by Novartis and as Pamimed by Curacell Biotech), is a nitrogen-containing bisphosphonate used to prevent osteoporosis. Contents 1 Uses 2 Administration 3 Side effects 4 References Uses It is used to prevent bone loss, and treat osteoporosis. It is also used to strengthen bone in Paget's disease, to prevent bone loss due to steroid use, and in certain cancers with high propens...

Read more Aredia Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Pamidronic_acid

Recent Aredia Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Pamidronate

Injection: 30mg, 30mg/10ml, 30mg/vial, 3mg/ml, 60mg, 60mg/vial, 6mg/ml, 90mg, 90mg/10ml, 90mg/vial, 9mg/ml, n/a

Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Pamidronate or a similar ingredient: (1 result)

PAMIDRONATE 4 discussions